Understanding how patients tolerate fluid removal during kidney support in the ICU
Official title: Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients
Run by Hospital Las Higueras · NCT07643597 · Data updated 2026-11-12
This observational study tests how well critically ill adults with acute kidney injury tolerate net fluid removal during continuous renal replacement therapy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 128 (estimated) |
| Sponsor | Hospital Las Higueras Academic / other |
| Locations | 10 sites (Salvador and 9 other locations) |
| Status | Recruiting |
| Started | July 6, 2026 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT07643597 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults in the ICU with AKI requiring CRRT with net ultrafiltration and who are clinically stable enough to start UFNET per treating team.
✕Probably not a fit
Patients who do not experience intolerance or who have contraindications to UFNET may not see a direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study follows adults with AKI in the ICU who are receiving CRRT with net ultrafiltration. It aims to identify factors—clinical, hemodynamic, ultrasound, perfusion, and biochemical—that predict ultrafiltration intolerance before overt hypotension occurs. No changes to treatment decisions are made by the study team; care remains with the treating clinicians. The study uses a multiparametric assessment to better understand who is at risk of intolerance during fluid removal.
Why it matters
Potential benefit: If successful, the findings could help tailor fluid removal strategies to reduce intolerance and related complications.
How similar studies have gone: Prior work suggests ultrafiltration tolerance is variable; this study builds on observational data but may be among the first to use a multiparametric approach for early risk identification.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Admission to an Intensive Care Unit * Acute kidney injury according to KDIGO criteria * Prescription of continuous renal replacement therapy (CRRT) with net ultrafiltration * Clinical stability considered sufficient to initiate net ultrafiltration according to the treating clinical team Exclusion Criteria: * Chronic kidney replacement therapy prior to ICU admission * Pregnancy * Limitation of therapeutic effort or goals-of-care decisions at admission or during the observation period * Inability to perform hemodynamic or perfusion assessment * Extracorporeal membrane oxygenation (ECMO) * Refusal to participate in the study
Where it's running
-
Hospital Las Higueras de Talcahuano
Talcahuano, Chile Recruiting -
Hospital Universitario San José de Popayán
Popayán, Colombia Recruiting -
Hospital General de Mexico
Mexico City, Mexico Recruiting -
Hospital Cárdio Pulmonar
Salvador, Brazil Not yet recruiting -
Hospital Clínico Regional de Concepción
Concepción, Chile Not yet recruiting -
Complejo Asistencial Dr. Victor Ríos Ruiz
Los Ángeles, Chile Not yet recruiting
Show 4 more locations
-
Hospital Clínico Dra. Eloísa Díaz Insunza de La Florida
Santiago, Chile Not yet recruiting -
Hospital General Enrique Garces
Quito, Ecuador Not yet recruiting -
Ospedale San Bortolo
Vicenza, Italy Not yet recruiting -
Hospital Nacional Cayetano Heredia
Lima, Peru Not yet recruiting
Study contacts
- Principal investigator: Gonzalo Ramírez-Guerrero, MD — Hospital Las Higueras de Talcahuano
- Study coordinator: Gonzalo Ramírez-Guerrero, MD
- Email: ramirezguerrero.g@gmail.com
- Phone: +56981746173
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Timing of kidney treatment in critically ill patients
This study is trying to find out if starting kidney treatment earlier can help critically ill patients with kidney injury feel better and have better outcomes.
-
Sodium bicarbonate for critically ill patients with metabolic acidosis and AKI
This trial tests whether giving sodium bicarbonate helps reduce major kidney problems 90 days later in adults with septic or critical illness and kidney injury.
-
Epidemiology and care for dialysis in ICU patients with severe acute kidney injury in Latin America
This project will collect and compare data on adults in ICUs across Latin America who need dialysis for severe acute kidney injury to see how they are treated and what outcomes they have.
-
Choosing Wisely recommendations for care in the intensive care unit
This project will try the Choosing Wisely approach in adult ICU patients in Sweden to see if using fewer unnecessary tests and interventions is safe.
-
Using renal resistive index to predict acute kidney injury in high-risk patients
This study is testing if measuring kidney blood flow using ultrasound can help doctors spot acute kidney injury earlier in high-risk patients in the intensive care unit.
-
Comparing standard and low-dose continuous renal replacement therapy for acute kidney injury
This study tests whether using a standard dose or a lower dose of a kidney treatment can help critically ill patients with acute kidney injury recover better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.